MedPath

A study to compare the efficacy of daily 4000 IU versus 6000 IU of oral vitamin D3 in the treatment of vitamin D deficient over weight and obese children.

Phase 3
Conditions
Health Condition 1: E660- Obesity due to excess calories
Registration Number
CTRI/2021/02/031591
Lead Sponsor
Dr Priya Setia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Overweight and obese defined as per Indian Academy of Pediatrics (IAP)

2.Vitamin D levels <20 ng/mL, as per global consensus recommendations, 2016

Exclusion Criteria

1.Pathological obesity (syndromic, monogenic, endocrine, drug induced)

2.Already taking vitamin D or calcium supplements in the last 3 months

3.Children with underlying co-morbidity including Chronic Liver Disease (CLD), Chronic Kidney Disease (CKD), type 1 Diabetes mellitus, thyroid dysfunction or any disorder that affects bone or mineral metabolism

4.Children who are taking anti-convulsants, anti-tubercular or steroid therapy

5.Children who have undergone surgery or are immobilized for more than 1 year

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath